Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28333042 | 0.79 | — | — | |
| SCHEMBL4334920 | 0.71 | ALDH1A1 (0.30) | ALDH1A1LMNA | |
| SCHEMBL27517433 | 0.69 | CA12 (0.33) | ALDH1A1LMNACA12CA1CA2 | |
| SCHEMBL28105511 | 0.68 | — | — | |
| SCHEMBL2343974 | 0.67 | CYP2C9 (0.34) | ALDH1A1LMNACA12CA1CA2 | |
| SCHEMBL6193368 | 0.65 | CA12 (0.34) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL10815505 | 0.64 | CA12 (0.35) | ALDH1A1LMNACA12CA1CA2 | |
| SCHEMBL28273227 | 0.64 | GABRA1 (0.33) | CA12CA1CA2CA9CA14 | |
| SCHEMBL1615450 | 0.62 | ELANE (0.33) | ALDH1A1LMNACA12CA1CA2 | |
| SCHEMBL4334916 | 0.62 | CA12 (0.32) | ALDH1A1LMNACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110551129-B | Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester | 常州合全药业有限公司 | 2021-11-09 | — | — | CN | claimed |
| CN-110551129-A | preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester | CHANGZHOU STA PHARMACEUTICAL CO LTD | 2019-12-10 | — | — | CN | claimed |
| CN-110551129-B | Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester | 常州合全药业有限公司 | 2021-11-09 | — | — | CN | disclosed |
| CN-110551129-B | Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester | 常州合全药业有限公司 | 2021-11-09 | — | — | CN | disclosed |
| CN-110551129-B | Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester | 常州合全药业有限公司 | 2021-11-09 | — | — | CN | disclosed |
| CN-110551129-A | preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester | CHANGZHOU STA PHARMACEUTICAL CO LTD | 2019-12-10 | — | — | CN | disclosed |
| CN-110551129-A | preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester | CHANGZHOU STA PHARMACEUTICAL CO LTD | 2019-12-10 | — | — | CN | disclosed |
| CN-110551129-A | preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester | CHANGZHOU STA PHARMACEUTICAL CO LTD | 2019-12-10 | — | — | CN | disclosed |